| MIR133B |
|
microRNA 133b
|
|
|
0.555 |
0.808 |
| MIR127 |
|
microRNA 127
|
|
|
0.553 |
0.692 |
| RPL17-C18orf32 |
|
RPL17-C18orf32 readthrough
|
|
0.58 |
0.572 |
0.615 |
| H3P12 |
|
H3 histone pseudogene 12
|
|
|
0.603 |
0.615 |
| PSC |
|
Cholangitis, primary sclerosing
|
|
|
0.603 |
0.731 |
| CASC2 |
|
cancer susceptibility 2
|
|
|
0.612 |
0.462 |
| MIR622 |
|
microRNA 622
|
|
|
0.638 |
0.500 |
| MIR761 |
|
microRNA 761
|
|
|
0.682 |
0.308 |
| CMD1B |
|
cardiomyopathy, dilated 1B (autosomal dominant)
|
|
|
0.722 |
0.500 |
| MIR1226 |
|
microRNA 1226
|
|
|
0.792 |
0.269 |
| RPSAP52 |
|
ribosomal protein SA pseudogene 52
|
|
|
0.931 |
0.154 |
| OS4 |
|
Osteoarthritis, generalized, without dysplasia, susceptibility to
|
|
|
|
|
| SIK1 |
A0A0B4J2F2 P57059
|
salt inducible kinase 1
|
Kinase
|
0.94 |
0.544 |
0.731 |
| SIK1B |
A0A0B4J2F2 P57059
|
salt inducible kinase 1B (putative)
|
|
|
0.653 |
0.385 |
| PERCC1 |
A0A1W2PR82
|
proline and glutamate rich with coiled coil 1
|
|
|
0.552 |
0.808 |
| C16orf96 |
A6NNT2
|
chromosome 16 open reading frame 96
|
|
5.6E-21 |
0.931 |
0.038 |
| AHRR |
A9YTQ3
|
aryl-hydrocarbon receptor repressor
|
Transcription factor
|
1.8E-04 |
0.666 |
0.577 |
| C11orf95 |
C9JLR9
|
chromosome 11 open reading frame 95
|
|
|
0.780 |
0.115 |
| PSMD9 |
O00233
|
proteasome 26S subunit, non-ATPase 9
|
Enzyme modulator
|
4.9E-06 |
0.435 |
0.846 |
| CLIC1 |
O00299
|
chloride intracellular channel 1
|
Ion channel
|
1.9E-04 |
0.601 |
0.500 |
| PIK3CD |
O00329
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta
|
Kinase
|
1.00 |
0.319 |
0.885 |
| DCTN6 |
O00399
|
dynactin subunit 6
|
Cellular structure
|
5.6E-02 |
0.442 |
0.769 |
| PLOD2 |
O00469
|
procollagen-lysine,2-oxoglutarate 5-dioxygenase 2
|
Enzyme
|
6.7E-08 |
0.559 |
0.654 |
| KRIT1 |
O00522
|
KRIT1 ankyrin repeat containing
|
|
6.9E-04 |
0.500 |
0.808 |
| FBP2 |
O00757
|
fructose-bisphosphatase 2
|
Enzyme
|
2.2E-04 |
0.839 |
0.231 |